T. YANIK Et Al. , "Risperidon (risperdal) therapy in schizophrenia: metabolic effects," 16th North American Regional ISSX Meeting , vol.41, Maryland, United States Of America, pp.186, 2009
YANIK, T. Et Al. 2009. Risperidon (risperdal) therapy in schizophrenia: metabolic effects. 16th North American Regional ISSX Meeting , (Maryland, United States Of America), 186.
YANIK, T., Kursungoz, C., Sutcigil, L., & Ozgen, F., (2009). Risperidon (risperdal) therapy in schizophrenia: metabolic effects . 16th North American Regional ISSX Meeting (pp.186). Maryland, United States Of America
YANIK, TÜLİN Et Al. "Risperidon (risperdal) therapy in schizophrenia: metabolic effects," 16th North American Regional ISSX Meeting, Maryland, United States Of America, 2009
YANIK, TÜLİN Et Al. "Risperidon (risperdal) therapy in schizophrenia: metabolic effects." 16th North American Regional ISSX Meeting , Maryland, United States Of America, pp.186, 2009
YANIK, T. Et Al. (2009) . "Risperidon (risperdal) therapy in schizophrenia: metabolic effects." 16th North American Regional ISSX Meeting , Maryland, United States Of America, p.186.
@conferencepaper{conferencepaper, author={TÜLİN YANIK Et Al. }, title={Risperidon (risperdal) therapy in schizophrenia: metabolic effects}, congress name={16th North American Regional ISSX Meeting}, city={Maryland}, country={United States Of America}, year={2009}, pages={186} }